Consolidated Portfolio Review Corp’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,710
Closed -$515K 93
2025
Q3
$515K Sell
9,710
-215
-2% -$11.7K 0.06% 264
2025
Q2
$470K Buy
9,925
+850
+9% +$37.6K 0.07% 268
2025
Q1
$375K Buy
+9,075
New +$357K 0.06% 266

Other funds holding BTI

Consolidated Portfolio Review Corp's BTI Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of British American Tobacco (BTI) in Q4 2025, closing a stake of 9,710 shares — an estimated $515K sold.

Consolidated Portfolio Review Corp first reported a position in BTI in Q1 2025 and held it in 3 quarters. The position peaked at $515K in Q3 2025. 823 funds tracked by Wall St. Rank hold BTI as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining British American Tobacco position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 9,710 British American Tobacco shares in Q4 2025, an estimated $515K.
  • Consolidated Portfolio Review Corp first reported a position in British American Tobacco in Q1 2025 and held it in 3 quarters.
  • Consolidated Portfolio Review Corp's British American Tobacco position peaked at $515K in Q3 2025.
  • 823 funds tracked by Wall St. Rank held British American Tobacco as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.